Jacobi Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jacobi Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-181	Closed	-$17K	–	1521
2021 Q2	$17K	Buy	181 +50	+38%	+$4.6K	﹤0.01%	889
2021 Q1	$12K	Buy	131 +88	+205%	+$7.43K	﹤0.01%	937
2020 Q4	$3K	Buy	43 +13	+43%	+$966	﹤0.01%	1138
2020 Q3	$2K	Buy	30 +13	+76%	+$894	﹤0.01%	1145
2020 Q2	$1K	Buy	+17	New	+$727	﹤0.01%	1214

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jacobi Capital Management's HZNP Position: Q3 2021 in Review

Jacobi Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2021, closing a stake of 181 shares — an estimated $17K sold.

Jacobi Capital Management first reported a position in HZNP in Q2 2020 and held it in 5 quarters. The position peaked at $17K in Q2 2021. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

Jacobi Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2021 after selling out during the quarter.
Jacobi Capital Management sold 181 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $17K.
Jacobi Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 5 quarters.
Jacobi Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $17K in Q2 2021.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Jacobi Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.